Molecular Detection of Extended-Spectrum Beta-Lactamases in Escherichia coli Isolated from Patients with Urinary Tract Infections

Background: Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) have emerged as a significant health concern due to the increasing prevalence of drug-resistant variants, especially those capable of generating extended-spectrum beta-lactamases (ESBLs), which complicate treatment options. These enzymes degrade beta-lactam antibiotics, limiting therapeutic options for UTIs. Objectives: Our study aimed to isolation and identification of Escherichia coli isolated from individuals diagnosed with urinary tract infections, testing antimicrobial susceptibility of isolated Escherichia coli isolates associated with urinary tract infections, phenotypic identification of Extended-Spectrum Beta-Lactamases isolated from urine samples and molecular identification of Extended-Spectrum Beta-Lactamases isolated from urine samples. Methodology: An overall number of 210 urine samples was acquired from patients suffering from UTIs. Of these, 115 bacterial isolates were confirmed to be E. coli. Susceptibility to antimicrobial agents was evaluated using the Kirby-Bauer disc diffusion method, combination disc test, double disc synergy test, genotypic test by polymerase chain reaction (PCR) for five genes 16s rRNA, blaTEM, blaSHV, blaCTXM, blaOXA. Results: Out of the 115 E. coli isolates, 40 (39.1%) were found to produce ESBLs. Molecular analysis showed that 62.2% of the ESBL-producing isolates carried the blaCTXM gene, followed by blaTEM (37.8%), blaSHV (26.7%), and blaOXA (17.8%). High resistance rates were observed against third-generation cephalosporins, such as Ceftriaxone (80%) and Cefotaxime (75%). Conclusion: This study highlights the widespread occurrence of ESBL-producing Escherichia coli strains in UTIs and emphasizes the importance of molecular detection for accurate diagnosis and effective treatment. The findings underline the need for antimicrobial stewardship programs to combat the spread of resistance.

Authors

Institutions

Publication Details

Journal
The Egyptian Journal of Medical Microbiology
Published
2025-06-30
DOI
https://doi.org/10.21608/ejmm.2025.393378.1706
Primary Topic
Urinary Tract Infections Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Detection of Extended-Spectrum Beta-Lactamases in Escherichia coli Isolated from Patients with Urinary Tract Infections

Rania M. Ewida, Rabia Hamid, Rehab M. Abdelbary, A. K. Hassab El-Nabi
The Egyptian Journal of Medical Microbiology
Urinary Tract Infections Management
article

Molecular Detection of Extended-Spectrum Beta-Lactamases in Escherichia coli Isolated from Patients with Urinary Tract Infections

Rania M. Ewida, Rabia Hamid, Rehab M. Abdelbary, A. K. Hassab El-Nabi
article en

Abstract

Background: Urinary tract infections (UTIs) caused by Escherichia coli (E. coli) have emerged as a significant health concern due to the increasing prevalence of drug-resistant variants, especially those capable of generating extended-spectrum beta-lactamases (ESBLs), which complicate treatment options. These enzymes degrade beta-lactam antibiotics, limiting therapeutic options for UTIs. Objectives: Our study aimed to isolation and identification of Escherichia coli isolated from individuals diagnosed with urinary tract infections, testing antimicrobial susceptibility of isolated Escherichia coli isolates associated with urinary tract infections, phenotypic identification of Extended-Spectrum Beta-Lactamases isolated from urine samples and molecular identification of Extended-Spectrum Beta-Lactamases isolated from urine samples. Methodology: An overall number of 210 urine samples was acquired from patients suffering from UTIs. Of these, 115 bacterial isolates were confirmed to be E. coli. Susceptibility to antimicrobial agents was evaluated using the Kirby-Bauer disc diffusion method, combination disc test, double disc synergy test, genotypic test by polymerase chain reaction (PCR) for five genes 16s rRNA, blaTEM, blaSHV, blaCTXM, blaOXA. Results: Out of the 115 E. coli isolates, 40 (39.1%) were found to produce ESBLs. Molecular analysis showed that 62.2% of the ESBL-producing isolates carried the blaCTXM gene, followed by blaTEM (37.8%), blaSHV (26.7%), and blaOXA (17.8%). High resistance rates were observed against third-generation cephalosporins, such as Ceftriaxone (80%) and Cefotaxime (75%). Conclusion: This study highlights the widespread occurrence of ESBL-producing Escherichia coli strains in UTIs and emphasizes the importance of molecular detection for accurate diagnosis and effective treatment. The findings underline the need for antimicrobial stewardship programs to combat the spread of resistance.

The Egyptian Journal of Medical MicrobiologyVol. 35(1)
Assiut University (EG)
Zero hunger
Openalex Percentile: Top 78%
Urinary Tract Infections Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.